| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |